Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Superglass, Akers Biosciences, TT electronics...

Fri, 14th Jan 2011 14:00

Insulation products maker Superglass is experiencing solid trading with specialist distributors and builders' merchants, but, as anticipated, there has been a slow start to the newly extended carbon emissions reduction target (CERT) programme. The expectation is that the company's trading performance will be significantly second half (March to August) weighted. "CERT remains the key driver of trading for the company in the short term and the factors underpinning growth in this channel are strengthening. However, the timing and rate of growth in demand arising from the CERT extension remains uncertain and will ultimately determine the outcome for the financial year," the company said.The BreathScan PRO alcohol detection system developed by Britain's Akers Biosciences is on sale in the US and Europe after receiving full market clearance from the US regulators this week."We expect the FDA-clearance and inefficiency of existing testing procedures will open up many doors for marketing opportunities," said boss Thomas Nicolette.Sensor and electronic component firm TT electronics traded as expected during the fourth quarter of 2010, with sales for the year from continuing operations about 24% ahead of 2009 at constant exchange rates. "The business traded well with consistently higher volumes during 2010 and has entered the new financial year with a good order book giving visibility into the second quarter," it said Friday. Telecommunications software group Globo expects profit before tax for 2010 to be in line with forecasts following a better than expected 31% increase in revenue to €30.9m.
More News
4 Nov 2014 16:15

UK AGM, EGM Calendar - Week Ahead

Read more
4 Nov 2014 08:21

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

Read more
4 Nov 2014 06:13

UK AGM, EGM Calendar - Week Ahead

Read more
3 Nov 2014 16:09

UK AGM, EGM Calendar - Week Ahead

Read more
23 Oct 2014 12:30

Akers Biosciences Inks Joint Venture Deal With Hainin Savy In China

Read more
9 Sep 2014 16:02

MARKET COMMENT: London Ends Mixed Amid Boost From Production Data

Read more
9 Sep 2014 11:46

Akers Biosciences Signs USD864,000 Tri-Cholesterol "Check" Sales Deal

Read more
15 Aug 2014 07:39

UK MORNING BRIEFING: Miners Lead Broad-Based London Gains

Read more
15 Aug 2014 06:46

Akers Biosciences Appoints Co-Chairman

Read more
12 Aug 2014 10:42

Akers Biosciences Posts Wider Loss But Rise In Flagship Product Sales

Read more
28 Jul 2014 10:20

Akers Inks Feasibility Study Deal With Konica For Heart Attack Tests

Read more
17 Jul 2014 10:18

Akers Biosciences Breath Device Granted Patent

Read more
25 Jun 2014 13:28

REPEAT: Akers Biosciences Inks Distribution Agreement With Medline Industries

Read more
25 Jun 2014 12:40

UK MIDDAY BRIEFING: AbbVie Sets Out Case For Shire Acquisition

Read more
25 Jun 2014 12:10

Akers Biosciences secures US distribution for heparin test

Shares in Akers Biosciences were higher on news that it had secured a major distribution agreement in the US for its test to determine if patients will have a reaction to blood thinner heparin. The company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries, which it said was

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.